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ORIGINAL ARTICLE

Transposon mutagenesis in Mycobacterium kansasii links a small
RNA gene to colony morphology and biofilm formation and
identifies 9,885 intragenic insertions that do not compromise
colony outgrowth
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Abstract
Mycobacterium kansasii (Mk) is a resilient opportunistic human pathogen that causes

Biology Ph.D. Program, Graduate Center,
City University of New York, New York, NY,
USA

tuberculosis-like chronic pulmonary disease and mortality stemming from comorbidi-
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long-term, multidrug courses with adverse side effects. The emergence of drug-re-
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ties and treatment failure. The standard treatment of Mk infections requires costly,
sistant isolates further complicates the already challenging drug therapy regimens
and threatens to compromise the future control of Mk infections. Despite the increasingly recognized global burden of Mk infections, the biology of this opportunistic pathogen remains essentially unexplored. In particular, studies reporting gene
function or generation of defined mutants are scarce. Moreover, no transposon (Tn)
mutagenesis tool has been validated for use in Mk, a situation limiting the repertoire
of genetic approaches available to accelerate the dissection of gene function and the
generation of gene knockout mutants in this poorly characterized pathogen. In this
study, we validated the functionality of a powerful Tn mutagenesis tool in Mk and
used this tool in conjunction with a forward genetic screen to establish a previously
unrecognized role of a conserved mycobacterial small RNA gene of unknown function in colony morphology features and biofilm formation. We also combined Tn mutagenesis with next-generation sequencing to identify 12,071 Tn insertions that do
not compromise viability in vitro. Finally, we demonstrated the susceptibility of the
Galleria mellonella larva to Mk, setting the stage for further exploration of this simple
and economical infection model system to the study of this pathogen.
KEYWORDS

biofilm, Galleria mellonella, gene essentiality, Mycobacterium kansasii, nontuberculous
mycobacteria, small noncoding RNA
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1 | I NTRO D U C TI O N

of other predisposing factors in the population (e.g., immunosup-

Chronic pulmonary disease (CPD) due to opportunistic infections

tissue is not uncommon, and, like primary lung infection, may lead to

pression and COPD). In addition, infection of skin and subcutaneous
of nontuberculous mycobacterial (NTM) pathogens from environ-

disseminated disease in people with a compromised immune system

mental sources has become an increasingly recognized global pub-

or other vulnerabilities (Brown-Elliott, Nash, & Wallace, 2012; Flor,

lic health problem (Kendall & Winthrop, 2013; Prevots & Marras,

Capdevila, Martin, Gavalda, & Pahissa, 1996; Henkle & Winthrop,

2015). At least forty NTM spp. are associated with CPD (Daley &

2015; Johnston & Elwood, 2011).

Griffith, 2010). The ubiquitous slow-growing Mycobacterium kansa-

The complex drug treatment of Mk CPD exacerbates the pub-

sii (Mk) is among the six most common NTM spp. associated with

lic health challenge this pathogen presents. Costly, long-term, mul-

CPD in the United States and many other areas of the world, where

tidrug courses with adverse side effects often reduce compliance

it is often surpassed only by the Mycobacterium avium complex

and positive treatment outcomes (Brown-Elliott et al., 2012; Griffith

(Davies, Roberts, Kaul, Klein, & Milburn, 2012; Hoefsloot et al.,

et al., 2007). A main first-line treatment in the Unites States has been

2013; Mirsaeidi, Farshidpour, Allen, Ebrahimi, & Falkinham, 2014;

a regimen that includes three anti-TB drugs (typically rifampin or ri-

Prevots & Marras, 2015). The burden of Mk infections is not sur-

fabutin, ethambutol, and isoniazid) daily until the patient has at least

prising given that the risk factors include HIV infection, pharmaco-

12 months of negative sputum cultures while on therapy (Griffith

logical immunosuppression, chronic obstructive pulmonary disease

et al., 2007; Philley & Griffith, 2015). Mk isolates resistant to TB

(COPD), malignancy, bronchiectasis, and previous mycobacterial dis-

drugs have been reported (Brown-Elliott et al., 2012; Lyons et al.,

ease (Maliwan & Zvetina, 2005; Prevots & Marras, 2015). Mk is often

2014; Wang et al., 2010; Wu et al., 2009; Yamada et al., 1997). In

present in human-made water systems, where it forms resilient bio-

particular, resistance to rifampin, a drug which has a key role in the

films (Chakraborty & Kumar, 2019; Kwenda et al., 2015; Vaerewijck,

multidrug treatment of Mk infections, correlates with higher rates

Huys, Palomino, Swings, & Portaels, 2005). Infection generally

of treatment failure and relapse (Brown-Elliott et al., 2012; Griffith

originates following inhalation, aspiration, ingestion, or local in-

et al., 2007; Wu et al., 2009). For patients with rifampin-resistant in-

oculation (Griffith et al., 2007; Vaerewijck et al., 2005). Although

fections, a usual guideline is a regimen based on in vitro-determined

person-to-person transmission has not been reported, some stud-

isolate susceptibilities to secondary agents (e.g., fluoroquinolones,

ies suggest that it might be possible, and the potential emergence

tetracyclines, amikacin, linezolid, trimethoprim-sulfamethoxazole,

of strains with an epidemiologically meaningful person-to-person

and rifabutin) and including at least three drugs (Griffith et al., 2007;

transmission capacity is a concern (Ricketts, O'Shaughnessy, & van

Philley & Griffith, 2015).

Ingen, 2014).
Mycobacterium kansasii has seven subtypes, with subtype 1 being

Despite the burden of Mk infections, the biology of this pathogen
remains poorly explored. Encouragingly, the completion of the Mk

by far the most prevalent in human isolates, followed by subtype

(subtype 1 strain) genome sequence was recently reported (Wang

2. The remaining subtypes are recovered from environmental sam-

et al., 2015), and various aspects of Mk biology have been inferred

ples almost exclusively (Bakula, Safianowska, Nowacka-Mazurek,

by bioinformatics and extrapolation from insights gained for Mtb

Bielecki, & Jagielski, 2013; Picardeau, Prod'Hom, Raskine, LePennec,

(Veyrier et al., 2009; Wang et al., 2015). However, the 6.57 Mb of

& Vincent, 1997; Taillard et al., 2003; Tortoli, 2003). Mk has a rel-

genetic material carried by Mk represents 2.16 Mb more than that

atively close phylogeny to the Mycobacterium tuberculosis (Mtb)

present in Mtb (Cole et al., 1998), and thus in silico approaches do not

complex and its related Mycobacterium canettii clade, and an Mk-like

provide a full picture and may even lead to flawed conclusions. In all,

opportunistic pathogen is believed to be an Mtb complex ancestor

it is clear that experimentation focused on Mk is needed to deepen

(Minnikin et al., 2015; Veyrier, Pletzer, Turenne, & Behr, 2009; Wang

our knowledge of its biology, further understand its ability to cause

et al., 2015). Moreover, Mk has been considered as a possible model

disease, and illuminate paths to better therapeutics. In particular, the

to explore the evolutionary transition from the environmental op-

scarcity of gene function studies and the lack of defined mutants

portunistic pathogen lifestyle to the obligate pathogen lifestyle seen

are major barriers to progress in the field. In fact, to our knowledge,

in the genus, and as a surrogate of Mtb for tuberculosis (TB) patho-

there are only four reported Mk gene function studies (Klein, Brown,

genesis studies (Minnikin et al., 2015; Wang et al., 2015).

& French, 2001; Nataraj et al., 2015; Onwueme, Vos, Zurita, Soll,

The CPD caused by Mk resembles TB and its mortality is as-

& Quadri, 2005; Sun & Zhang, 1999). Moreover, no transposon (Tn)

sociated with comorbidities and treatment failure (Ehsani, Reddy,

mutagenesis tool has been validated for use in Mk, a situation limit-

Mosunjac, Kraft, & Guarner, 2015; Evans et al., 1996; Hirashima

ing the repertoire of genetic approaches to accelerate gene function

et al., 2014; Maliwan & Zvetina, 2005). Relapses occur often (≈10%)

dissection in this pathogen.

and cure rates are only 80%–90% (Davies et al., 2012; Mirsaeidi

In this study, we explored the use of genome-wide Tn muta-

et al., 2014; Santin et al., 2009). The prevalence of Mk CPD remains

genesis-based approaches to interrogate gene function in Mk. We

under-recognized, particularly in high TB-HIV burden areas, due to

provide proof-of-principle for the application of these approaches

overlapping features with TB, lack of proper diagnosis, and absence

to Mk by using them to (a) link a conserved small RNA (sRNA) gene

of compulsory reporting policy. Nevertheless, it is clear that Mk CPD

to colony morphology and biofilm formation and to (b) identify

continues to rise with the enduring HIV epidemic and the increase

≈12,000 Tn insertions that do not impede colony outgrowth. Lastly,

|
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we present the first demonstration of the susceptibility of Galleria
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supplemented 7H9 medium lacking Tween-80), and concentrated

mellonella (GM) larvae to Mk, thus setting the stage for further explo-

10 times in PB. Mk suspension aliquots were combined with phage

ration of the GM infection model system to study this opportunistic

stock aliquots to obtain transduction mixtures with desired PFU-

pathogen.

to-CFU multiplicity of infection (MOI) values. MOIs of 0.3:1 and
1:1 (average) were used in the transductions for generation of the
mutant libraries used in the genetic screen and the transposon in-

2 | M ATE R I A L S A N D M E TH O DS

sertion sequencing experiment, respectively. Mock transduction

2.1 | Routine culturing conditions, molecular
biology techniques, and reagents

of PB to the cell suspensions. Transduction mixtures and mock

controls were routinely prepared by adding equivalent volumes
controls were incubated at 37°C without shaking for 4 hr. After
incubation, aliquots of transduction mixtures and mock controls

Mycobacteria were cultured under standard conditions in

were used to enumerate Km resistant (Km R ) CFU and total CFU on

Middlebrook 7H9, 7H10, or 7H11 media (Difco, Becton-Dickinson

agar plates with and without Km, respectively. The remainder of

and Co.) supplemented as reported (Chavadi, Edupuganti, et al.,

each transduction mixture was made 10% glycerol, aliquoted, and

2011; Chavadi, Stirrett, et al., 2011). Mk cultures were agitated

stored at −80°C until use.

at 170 rpm with a few sterile glass beads (3 mm diameter) to reduce aggregation. Mk growth curve experiments were carried
out using a 96-well plate-based growth assay we reported previ-

2.3 | Arrayed library preparation

ously (Chavadi, Edupuganti, et al., 2011), except that the plates
were incubated at 37°C. Where appropriate, kanamycin (Km,

Transduction mixtures were plated on supplemented Middlebrook

30 µg/ml) and/or hygromycin (Hyg, 150 µg/ml) were added to

7H10 medium with Km to obtain 100 Tn mutant colonies per plate.

the Middlebrook media. Culturing of Escherichia coli strains was

The plates were incubated at 37°C for three weeks for KmR colony

done under standard conditions in Luria–Bertani broth and agar

growth. The KmR colonies were picked and individually arrayed

media (Sambrook & Russell, 2001). When required, ampicillin

in 96-well plates (Falcon, Corning) preloaded with supplemented

(Amp, 100 µg/ml), Km (30–50 µg/ml), Hyg (150 µg/ml), and/or

Middlebrook 7H9 medium with Km (200 µl/well). The 96-well plates

5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-Gal, 56 μg/

were incubated at 37°C with orbital shaking (170 rpm) under a hu-

ml) were added to the Luria–Bertani media. DNA manipulations

midified atmosphere for 8 days to grow the microcultures. After in-

were carried out using established protocols and E. coli as the

cubation, the microcultures were homogenized with a multichannel

primary cloning host (Sambrook & Russell, 2001). PCR-generated

pipette and replicate inoculated (1.5 µl transfer) with a 96-pin inocu-

DNA fragments used in plasmid constructions were sequenced

lator (Clonemaster™; Immusine Laboratories, Inc.) into new 96-well

by the Sanger method to verify fidelity (Genewiz, Inc.). Sequence

culture plates preloaded with fresh medium. The inoculated plates

alignments were carried out using DNASTAR's Lasergene se-

were then incubated as described above for microculture growth.

quence analysis software (DNASTAR, Inc.). Predictions of sRNA

After incubation, the microcultures were made 4% glycerol and

structures and minimum free energies were obtained with mFold

the 96-well library plates were sealed with sterile adhesive foil film

software using default parameters (Zuker, 2003). Isolation of Mk

sheets and stored at −80°C until use.

genomic DNA, plasmid electroporation into Mk, and selection of
Mk transformants were carried out following standard methodologies (Chavadi, Edupuganti, et al., 2011; Chavadi, Stirrett, et al.,

2.4 | Morphology screen

2011). Unless otherwise indicated, reagents were purchased from
Sigma-Aldrich Inc., Thermo Fisher Scientific Inc., New England

The microcultures in the 96-well library plates were defrosted

Biolabs Inc., Qiagen LLC , or VWR International, LLC. The strains

and homogenized with a multichannel pipette. The microcultures

and oligonucleotides used in this study are listed in Tables A1 and

of each library plate were then subcultured into a pair of 96-well

A2, respectively (Appendix 1).

plates (5 µl inoculum into a well preloaded with 195 µl of medium)
using an every-other-well redistribution pattern. The inoculated

2.2 | Phage stock preparation, transductions, and
transposon mutant selection

96-well plates were incubated to grow the microcultures to latelog phase. Following the incubation, the microcultures were homogenized as above, and 1.5 µl of each microculture was spotted
onto supplemented 7H10 plates using a 96-pin inoculator. The

High-titer stocks (≈1011 PFU/ml) of the ϕMycoMarT7 phage were

inoculated screen plates were incubated at 37°C until most mac-

generated and titrated using Mycobacterium smegmatis (Msm) as

rocolonies reached 0.5–1.0 cm in diameter (≈18 days). After incu-

reported (Siegrist & Rubin, 2009). For Mk transductions, bacte-

bation, the screen plates were scrutinized for macrocolonies with

ria from actively growing cultures were harvested by centrifuga-

mutant phenotypes by naked eye and using an Olympus SZX7 ste-

tion, washed twice with 1 culture volume of phage buffer (PB:

reo microscope (Olympus Corp.).

4 of 22
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2.5 | Southern blot hybridization analysis

2.8 | RNA isolation

Samples of genomic DNA (0.5–1.0 µg) digested with SacII (an en-

Pellets containing 1–5 × 107 CFU of Mk grown in supplemented

zyme that does not cut within the Tn) were separated alongside a

Middlebrook 7H9 medium to log phase or scrapings of equivalent

prestained DNA molecular weight marker (F. Hoffmann-La Roche,

mass taken from macrocolonies grown at 37°C for 23 days on supple-

Ltd.) by electrophoresis in a 0.7% agarose gel. After electrophore-

mented Middlebrook 7H10 plates were resuspended in 1 ml TRIzol™

sis, the DNA on the gel was denatured and transferred onto a nylon

reagent (Invitrogen™). The resuspended cells were lysed with zirconia/

membrane (Amersham Hybond N+; GE Healthcare Life Sciences) as

silica beads (Bio Spec Products Inc.) in a bead-beater homogenizer

reported (Quadri, Sailer, Roy, Vederas, & Stiles, 1994). The Tn-specific

(Mini-BeadBeater 16, Bio Spec Products Inc.) using two bead-beating

512-bp DIG-labeled DNA hybridization probe was generated by PCR

cycles of 50 s each separated by a 10-min chilling step on ice. The

amplification using primers GG1 and GG2 and a PCR DIG-labeled

lysates were spun (22,000 g, 2 min, 4°C) to pellet beads and cellular

probe synthesis kit (F. Hoffmann-La Roche, Ltd.) according to man-

debris. The supernatants were transferred to siliconized microcen-

ufacturer's instructions. The probe was used for the hybridization

trifuge tubes, combined with 300 µl of chloroform:isoamyl alcohol

analysis following reported protocols (Quadri et al., 1994; Sambrook

(24:1), shaken vigorously for 15 s, and incubated at room temperature

& Russell, 2001) and visualized by chromogenic detection using a

for 3 min. After incubation, the samples were centrifuged (12,000 g,

DIG-labeled DNA detection kit (F. Hoffmann-La Roche, Ltd.) accord-

15 min, 4°C), and the RNA was isolated from the supernatant using

ing to the DIG Application manual (F. Hoffmann-La Roche, Ltd.).

PureLink™ RNA Mini and miRNA Isolation Kits (Invitrogen™) following
the manufacturer's instructions.

2.6 | Identification of the transposon insertion site
in Mycobacterium kansasii 13D6

2.9 | Northern blot analysis

Cloning of the Tn-containing genomic fragment and Tn-genome

Total RNA (1 µg, originated from 2 × 106 CFU) was separated on a

junction sequencing were carried out as reported (Siegrist & Rubin,

6% denaturing polyacrylamide gel (Novex precast 6% TBE-Urea po-

2009). Briefly, genomic DNA digested with SacII was self-ligated

lyacrylamide gel, Invitrogen™) run in a XCell SureLock™ Mini-Cell

and transformed into E. coli DH5α λpir for rescue cloning of Tn-

(Invitrogen™) according to manufacturer's protocols. Prestained

containing genomic fragments. The cloned plasmids were purified,

molecular weight markers (DynaMarker DM270; BioDynamics

and the Tn-genome junctions were sequenced using primers CB2

Laboratory Inc.) were separated alongside Mk total RNA and the

and CB2b. The genomic sequences identified were mapped onto the

100-bp hybridization probe fragment (see below), which was used

Mk ATCC 12478 genome (chromosome: GenBank NC_022663.1;

as reference for maker size calibration. After electrophoresis, the gel

plasmid pMK12478: GenBank NC_022654.1).

was electroblotted onto a nylon membrane (Amersham Hybond N+;
GE Healthcare Life Sciences) using a XCell SureLock™ Mini-Cell Blot

2.7 | Construction of plasmids pML-B11 and
pML1335ΔxylE

Module (Invitrogen™) in the XCell SureLock™ Mini-Cell according to
manufacturer's instructions and subsequently baked for 2 hr at 80°C.
An Mk B11-specific DIG-labeled hybridization probe (100 bp; genome
coordinates 2810109–2810208) was generated by PCR amplification

To generate pML-B11, vector pML1335 (Huff, Czyz, Landick, &

using primers CB9c3 and CB8c and a PCR DIG-labeled probe synthe-

Niederweis, 2010) was digested with BspHI and NotI to excise the

sis kit (F. Hoffmann-La Roche, Ltd.) according to manufacturer's in-

xylE marker segment. The resulting linearized vector backbone was

structions. The probe was used for the hybridization analysis following

ligated to a BspHI-NotI fragment encompassing the Mk B11 gene

reported protocols (Quadri et al., 1994; Sambrook & Russell, 2001)

along with its adjacent extragenic regions (chromosomal coordi-

and visualized by chromogenic detection using a DIG-labeled nucleic

nates 2809862–2810381, 520 bp). The fragment was generated

acid detection kit (F. Hoffmann-La Roche, Ltd.) according to the DIG

by PCR amplification from genomic DNA using primers CB3 and

Application manual (F. Hoffmann-La Roche, Ltd.).

CB7, cloned into pCR2.1-TOPO (TOPO TA cloning kit; Invitrogen),
sequenced for fidelity verification, and then subcloned into the
pML1335 backbone as noted above to create pML-B11. The se-

2.10 | RT-qPCR analysis

quence of B11 determined for the ATCC® 12478™ strain used in
this study was found to have a hepta-C string instead of the hexa-

The experiments were done using transcript target-specific primer

C string in the annotated chromosome (GenBank: NC_022663.1)

pairs (Table A2 in Appendix 1) and the QuantiNova® SYBR® Green

that maps to the loop of the middle stem-loop of the sRNA.

RT-PCR Kit as recommended by the manufacturer (Qiagen, LLC ). All

Plasmid pML1335ΔxylE (empty vector control) was generated by

primer pairs were optimized to have >90% amplification efficiency

removal of the xylE marker segment of pML1335 and subsequent

(as judged by standard curves generated from genomic DNA) and

vector backbone religation.

to produce a unique amplicon (as judged by melt curve analysis) of

|

BUDELL et al.

the expected size (as judged by agarose gel electrophoresis). RNA
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2.13 | Transposon insertion sequencing experiment

samples used for RT-qPCR were DNase-treated and verified to be
free of DNA contamination by PCR. One-step RT-qPCR reactions (10

Colonies from a library of ≈14,700 Tn mutants were scraped from

µl, 30 pg of RNA template) were run in a Rotor-Gene Q light cycler

supplemented 7H11 plates, and genomic DNA was isolated from

(Qiagen, LLC). Two-step PCR cycling was performed as follows: 95°C

the mutant pool as reported (Chavadi, Stirrett, et al., 2011). A

for 5 s and 60°C for 10 s for 40 cycles. For each transcript target,

modified TraDIS-type method (Fan et al., 2018; Langridge et al.,

the threshold cycle (Ct) was normalized to the Ct of the standard my-

2009) customized for the Himar1-based Tn in ϕMycoMarT7 was

cobacterial internal calibrator sigA transcript to generate transcript

used to identify the insertion sites in the genomic DNA library

relative abundance data as reported (Dubnau, Fontan, Manganelli,

pool. Briefly, genomic DNA was fragmented to a ≈350-bp aver-

Soares-Appel, & Smith, 2002; Livak & Schmittgen, 2001).

age length and adaptor sequences were ligated to each end of
the fragments using the KAPA HyperPlus Kit (Kapa Biosystems,

2.11 | Biofilm formation

Inc.) as recommended by the manufacturer. Two rounds of optimized PCR reactions (PCR-1 and PCR-2) were performed to enrich
for Tn-genomic DNA junction fragments and make the final PCR

The biofilm formation assay was carried out using the MBEC™

product suitable for Illumina sequencing. PCR-1 was done with a

device (Innovotech Inc.) and a protocol comparable to one we

Tn-specific primer (CB1) and an adapter-specific primer (IS5) for

recently reported (Mohandas et al., 2016). Briefly, Mk cells from

Tn-genome junction enrichment. PCR-2 (hemi-nested) was run

actively growing cultures were harvested by centrifugation and

with the adapter-specific primer IS5 and a Tn-specific primer add-

resuspended to an OD 600 of 0.1 in Middlebrook 7H9 lacking ADN

ing the sequences needed for Illumina sequencing and barcoding

supplementation (Chavadi, Stirrett, et al., 2011) and Tween-80.

of each sample (primers CB25.3_R or CB44.3_R). (See Appendix 3

The cell suspensions were loaded (150 µl/well) into the 96-well

) The generated fragment libraries were sequenced on an Illumina

plates, and the plates were incubated with 100 rpm agitation at

NextSeq 500 System using a NextSeq500/550 Mid Output Kit

37°C for 6 weeks under a humidified atmosphere. After incuba-

(150 cycles; 2 × 75 cycles; paired-end reads; Illumina Inc.). Custom

tion, Mk culture-exposed pegs and sterile broth-exposed control

primers were spiked to initiate the index read (primer barcodeseq)

pegs were washed twice with distilled water, briefly dried at room

and read two sequencing (primer SP2). Raw sequencing read data

temperature, stained for 15 min with 0.5% crystal violet (CV),

were processed as follows. (a) Duplicate reads (same sequences

rinsed thrice with distilled water, and dried overnight. The CV on

for paired-end reads, considered PCR siblings) were compressed

the pegs was then extracted in 95% ethanol and quantified spec-

into a single representative read. (b) Reads were filtered further

trophotometrically at 595 nm using a DTX 880 multimode detec-

based on the presence of the terminal 5-bp Tn sequence (TGTTA)

tor microplate reader (Beckman Coulter, Inc.).

adjacent to the Tn primer (CB25.3_R or CB44.3_R). (c) The primer
sequences were trimmed. (d) Each filtered and trimmed read was

2.12 | Galleria mellonella larva killing assay

mapped onto the Mk chromosome (GenBank: NC_022663.1) and
plasmid pMK12478 (GenBank: NC_022654.1) sequences using
BLAST (https://blast.ncbi.nlm.nih.gov/BLAST).

The assay was carried out using an infectious dose and methodologies comparable to those recently reported for other slowgrowing mycobacteria (Li et al., 2018). Larvae in the sixth instar
stage were purchased from Timberline Fisheries, Corp. (Marion,
IL) and used the day of delivery. Only larvae displaying healthy
movement, no melanization signs, and 150–250 mg body weight

3 | R E S U LT S A N D D I S CU S S I O N
3.1 | Evaluation of the ϕMycoMarT7 transposon
mutagenesis system in Mycobacterium kansasii

were used in the experiments. Larvae were restrained for injection
as reported (Dalton, Uy, Swift, & Wiles, 2017), and injections were

The ϕMycoMarT7 phagemid system has been the most success-

given into the last left pro-leg using a 22 s ga beveled stainless

ful Tn mutagenesis approach for mycobacteria thus far (Sassetti,

steel needle affixed to a 50-µl Hamilton syringe. For each experi-

Boyd, & Rubin, 2001). The system relies on specialized transduc-

ment, groups of 15 larvae were injected with 10 µl of either sterile

tion by a temperature-sensitive mycobacteriophage to deliver a

phosphate-buffered saline [PBS (Li et al., 2018)] or PBS carrying

Himar1 derivative Tn. The Tn inserts randomly at TA dinucleotide

1 × 107 CFU, or not injected. Each larval group was placed in a

sites via a cut-and-paste mechanism dependent on a transposase

paper-lined 10-cm petri dish, and the dishes were incubated in the

encoded outside the Tn in ϕMycoMarT7. In susceptible hosts, the

dark at 37°C or 25°C and observed daily for larva survival. Larvae

ϕMycoMarT7 phage typically defaults to a lytic cycle at the permis-

were considered dead when no movement was elicited upon phys-

sive temperature (30°C), but it does not replicate and becomes an

ical stimulation. Kaplan–Meier curves were used to plot survival

effective Tn delivery suicide vector at the nonpermissive tempera-

data, and the Log-rank (Mantel-Cox) test embedded in Prism v6.01

ture (37°C). The system has been demonstrated to be functional in

(GraphPad Software, Inc.) was used for curve comparisons.

a few Mycobacterium spp. (Mtb, Msm, M. bovis BCG, M. avium subsp.

6 of 22
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paratuberculosis, M. marinum, and M. fortuitum) (Driessen et al., 2010;

envelope surface properties with an impact on biofilm formation

Sassetti et al., 2001; Wang, Pritchard, Kreitmann, Montpetit, & Behr,

capacity, a trait linked to the public health problem associated with

2014). However, it is not expected to work in all Mycobacterium

Mk. Environmental Mk biofilms are considered recalcitrant pathogen

spp. due to phage host range, Tn functionality, or other limitations

reservoirs, and biofilm formation in the host is thought to contribute

(Bardarov et al., 1997; Rybniker, Kramme, & Small, 2006). Ultimately,

to the intractability of mycobacterial infections (Aldridge, Keren, &

the functionality of the system in any given Mycobacterium sp. needs

Fortune, 2014; Chakraborty & Kumar, 2019). Thus, identification of

to be experimentally determined.

genes involved in biofilm formation will lead to a better understand-

Due to the advantages of the ϕMycoMarT7 system, we set out
to evaluate its performance in Mk. To this end, we first assessed the

ing of Mk biology and illuminate potential paths to new therapeutics
and strategies for pathogen reservoir eradication.

ability of the phage to produce plaques on Mk lawns at the permis-

For the pilot screen, we generated a library of several hundred Tn

sive and nonpermissive temperatures. As a control, we carried out the

mutants arrayed in 96-well plates, spot-inoculated the library onto

equivalent experiment using lawns of Msm, the standard host for ϕMy-

solid growth medium plates, incubated the screen plates for mac-

coMarT7 phage propagation and titration. These experiments revealed

rocolony growth, and then scrutinized the plates for mutants with

that the phage was able to produce plaques on Mk lawns only at the

macrocolony abnormalities. We identified a mutant (herein referred

permissive temperature (Figure 1a) and that the plaque formation ef-

to as 13D6) visibly distinct from the wild type (WT) (Appendix 2,

ficiency was ≈800-fold lower in the pathogen than in Msm (Figure 1b).

Figure A1) and selected it for further analysis. We found that the

The latter finding suggests that either the infection step or the lytic

typical 13D6 macrocolony had a reduced diameter, abnormal sur-

cycle, or both, is less efficient in Mk. Overall, these results demon-

face topology, and a smooth and glistening appearance that con-

strate that the ϕMycoMarT7 phage infects Mk and its temperature

trasted the rough and dried phenotype of the WT (Figure 2a). The
distinct phenotype of the mutant was even more evident on streak

sensitivity trait is maintained in this pathogen.
We next investigated whether ϕMycoMarT7 could deliver

plates (Figure 2b). Single colonies of 13D6 were also reduced in size

the Tn to Mk at the nonpermissive temperature to give rise to Tn

(Figure 2c) and displayed an atypical surface appearance (Figure 2d)

mutants. We carried out Mk transductions and followed each of

compared to WT. Notably, the mutant displayed cell shape and plank-

them with selective outgrowth and enumeration of Km R colo-

tonic growth comparable to that of the parental strain (Appendix 2,

nies. We also carried out mock transduction control experiments

Figure A2).

R

Colony morphology is a trait influenced by multiple factors. It is

mutants under our experimental conditions. In all, we found that

well documented that mycobacterial mutants with abnormal colony

the number of Tn mutants increased with the MOI used in the

morphology often carry mutations in genes implicated in metabo-

transduction mixture (Figure 1c) and observed no meaningful fre-

lism of complex glycolipids of the outer membrane-like structure

(phage omitted) to determine the frequency of spontaneous Km

R

6

quency of spontaneous Km colonies (less than 1 in 10 CFU; not

(i.e., the mycomembrane) of the mycobacterial cell envelope, (Ren

shown). Lastly, the results of the transposon insertion sequencing

et al., 2007; Tatham et al., 2012; Yu et al., 2012). In particular, al-

(TIS) experiment described below confirmed that the TA site spec-

terations in the content of mycomembrane glycolipids known as

ificity of the Tn is preserved in Mk. In all, our results demonstrate

lipooligosaccharides (LOS) have been linked occasionally to smooth-

that the ϕMycoMarT7-based Tn mutagenesis system is fully func-

rough morphotype changes in Mk (Belisle & Brennan, 1989; Nataraj

tional in Mk.

et al., 2015). Thus, it is tempting to speculate that the abnormal
(macro)colony appearance of the 13D6 mutant suggests that the

3.2 | A Mycobacterium kansasii transposon mutant
library screen links a conserved sRNA gene of
unknown function to colony morphology

Tn insertion led to changes in mycomembrane composition and/or
structure.
We verified that 13D6 had a single Tn insertion (Appendix
A2, Figure A3) and identified the insertion site. We found that the
Tn had inserted 6 bp upstream of what we propose is a nonanno-

The realization that the ϕMycoMarT7 system is functional in Mk opens

tated sRNA gene orthologous to a nonessential Mtb sRNA gene of

the possibility to explore its use in forward genetic screens to unveil

unknown function named B11 (a.k.a. ncRv13660c) (Arnvig, Cortes, &

genotype-phenotype associations and dissect gene function. To pilot

Young, 2014; Arnvig & Young, 2009; DeJesus et al., 2017) (Figure 3a).

this concept, we carried out a small screen for macrocolony morphol-

The two orthologs have high sequence identity (Figure 3b), and

ogy mutants. We note that the term “macrocolony” used herein refers

their sRNA products have essentially the same predicted secondary

to the growth arising from spot inoculation (multi-CFU seeding) from a

structure (Figure 3c). Following the new nomenclature guidelines

liquid culture onto solid growth media, a colonial growth often consid-

for naming mycobacterial noncoding sRNAs (Lamichhane, Arnvig, &

ered a biofilm community (e.g., Chapelais-Baron et al., 2018; Kempes,

McDonough, 2013), we named the predicted Mk sRNA gene ncM-

Okegbe, Mears-Clarke, Follows, & Dietrich, 2014).

KAN_RS112130c (herein referred to as Mk B11 for simplicity). Our

We selected a macrocolony morphology screen for our concept

cross-species genome sequence similarity analysis revealed that

exploration because we hypothesized that it might lead to identifi-

the B11 gene locus is highly conserved in the Mycobacterium genus

cation of mutants with insertions in genes involved in defining cell

(Appendix 2, Figure A4a) and in many representative members of
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Mk

(a)
30°C

Msm
37°C

30°C

1×10 12

(b)
37°C

1×10 11
1×10 10
PFU/ml

UD

10 –1

1×10 9
1×10 8
1×10 7
1×10 6
1×10 5

10 –2

Undisturbed
lawn

10 –3

1×10 4

Msm

Mk

Undisturbed
lawn

(c)

1×10 –4

10 –4

10 –5

Frequency of Km R CFU
(Km R CFU/total CFU)

F I G U R E 1 Functionality of the
ϕMycoMarT7-based transposon
mutagenesis system in Mycobacterium
kansasii. (a) Images showing the plaque
formation capacity of the ϕMycoMarT7
phage on lawns of Mk and Msm at the
permissive (30°C) and nonpermissive
(37°C) temperatures. The numbers to
the left of the image represent a 10-fold
dilution series of the phage stock. UD,
undiluted phage stock. (b) Comparison
of plaque formation efficiency on
lawns of Mk and Msm at the permissive
temperature. The data represent
mean ± SE of at least two PFU titrations.
(c) Effect of the multiplicity of infection
(MOI) used in the transduction mixture
on the efficiency of generation of Mk Tn
mutants
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Undisturbed
lawn

10 –6

1×10 –5

1×10 –6

1×10 –7
0.01

10 –7

0.1

MOI

1

10

10 –8

other genera of Actinobacteria (not shown). These findings are con-

cells (Figure 5a) and planktonic cells (Figure 5b), respectively, rela-

sistent with reported analyses (DiChiara et al., 2010; Mai et al.,

tive to WT. Conversely, the insertion had no significant impact on

2019; Weinberg et al., 2007). The conservation of this gene sug-

the transcript levels of the flanking genes in either macrocolony

gests that its sRNA product has a critical function in the biology of

(Figure 5c) or planktonic (Figure 5d) cells. Thus, we conclude that the

Actinobacteria.
Based on the position of the Tn in the 13D6 mutant, we hypoth-

Tn insertion essentially shut down B11 transcription from its native
promoter, and attribute the residual B11 transcript detected in the

esized that the insertion might have abolished B11 transcription by

mutant by the highly sensitive RT-qPCR analysis to Tn-driven trace

separating the gene from its promoter. Consistent with this idea, the

transcription of the downstream B11 gene, a view supported by the

Mk B11 5′ flanking region contains a putative SigA-dependent pro-

literature on the Tn delivered by ϕMycoMarT7 (Rubin et al., 1999;

moter (Figure 3b), a feature conserved in the Mtb B11 locus (Arnvig

Zhang et al., 2012).

& Young, 2009). We found the equivalent putative promoter se-

In light of these results, we hypothesized that the lack of WT

quence upstream of the B11 orthologs in other Mycobacterium spp.

levels of B11 transcription in the 13D6 mutant led to the morphol-

(Appendix 2, Figure A4b). To investigate the hypothesized impact

ogy phenotype. To test this idea, we engineered and analyzed the

of the Tn insertion in 13D6 on B11 expression, we compared B11

phenotype of a genetic complementation control strain (13D6-c).

transcript levels between the 13D6 and WT strains by northern

The strain was generated using the plasmid pML-B11 to endow

blot analysis of RNA isolated from planktonic cultures and by RT-

13D6 with a WT copy of the B11 locus by plasmid integration at

qPCR analysis of RNA isolated from macrocolonies and from plank-

the mycobacteriophage L5 attB site of the Mk chromosome (co-

tonic cultures. We also assessed whether the transcript levels of

ordinates 1225397–1225458; Appendix 2, Figure A5), which we

the genes flanking B11 (i.e., MKAN_RS12130 and MKAN_RS12135;

identified using the Msm attB site as reference sequence (Lee,

Figure 3a) had been altered in 13D6. The northern blot analysis

Pascopella, Jacobs, & Hatfull, 1991). pML-B11 carries B11 along

revealed an sRNA transcript (≈80 nt) in the expected size range in

with its adjacent extragenic regions (Figure 3a), which were in-

the WT strain but not in the mutant (Figure 4a). In agreement with

cluded in the cloned fragment to preserve any unrecognized

this, the RT-qPCR analysis showed that the insertion led to reduc-

cis-acting elements that might have been required for control of

tions in transcript levels of 769-fold and 833-fold in macrocolony

B11 transcription or B11 transcript termination or processing. We
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F I G U R E 2 Morphology phenotypes
of Mycobacterium kansasii strains. (a)
Representative spot inoculation-derived
macrocolonies showing morphological
features. Scale bar = 2 mm. (b) Plates
with bacterial streaks (top; scale
bar = 1 cm) and enlargements (bottom;
scale bar = 2 mm) of the boxed sections
showing surface topology and appearance
features. (c) Plates with isolated single
colonies. Scale bar = 1 cm. Colony
diameter (cm) information is presented
below each plate. The values shown
represent mean ± SE. *Student's t test p
values <.05; ns, no significant difference
(p ≥ .05). (d) Representative single
colonies showing morphology detail. Scale
bar = 2 mm. WT, wt-v; M, 13D6-v; C,
13D6-c

also constructed an empty vector (pML1335ΔxylE )-carrying control

complementation is likely due to incomplete restoration of B11 tran-

of 13D6 (strain 13D6-v) and one of the WT (strain wt-v), and in-

script levels. Overall, our findings establish a previously unrecognized

cluded these strains in the complementation analysis. Evaluation

role of Mk B11, or any mycobacterial sRNA gene, in the development

of the morphology phenotype of the various strains revealed that

of (macro)colony morphology features.

empty vector integration had no impact on the phenotype of the
mutant, whereas integration of pML-B11 led to a strong partial
complementation (Figure 2).
The partial complementation seen in 13D6-c led us to assess

3.3 | Disruption of B11 transcription leads to biofilm
formation deficiency

whether the transcript level of B11 in the strain had indeed been restored to WT levels. We found that integration of pML-B11 in 13D6

As noted above, we theorized that our macrocolony morphology

raised the B11 transcript level 179-fold (to 23.30% of WT) in mac-

screen could lead to identification of mutants with insertions in

rocolony cells (Figure 5a) and 373-fold (to 44.81% of WT) in plank-

genes involved in defining cell surface properties with an impact

tonic cells (Figure 5b) as judged by RT-qPCR analysis. The results are

on biofilm formation, a trait that contributes to the pathogen's re-

in good agreement with those derived from the northern blot analysis,

silience in environmental reservoirs and in the host. Thus, we inves-

which indicates a B11 transcript level recovery of 34.14% in the plank-

tigated the effect of the Tn insertion in 13D6 on biofilm formation

tonic cells of 13D6-c relative to WT levels (Figure 4b). In light of the

using the MBEC™ device. Comparison of the WT and mutant strains

results of the B11 expression analysis, we conclude that the partial

in biofilm experiments revealed that only the WT formed biofilm
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F I G U R E 3 Mycobacterium kansasii 13D6 has a transposon insertion located 6 bp upstream of an sRNA gene (Mk B11) orthologous to the
Mycobacterium tuberculosis sRNA gene B11. (a) Outline depicting the Tn (Escherichia coli replication origin oriR6k and aph KmR marker are
represented), the location of the TA insertion site (chromosomal coordinates are shown), and the conservation of genetic features nearby the
insertion site in the Mk chromosome (NC_022663.1) and the orthologous segment in the Mtb chromosome (NC_000962.3). Chromosomal
coordinates of the segments are indicated. The coordinates of the chromosomal fragment included in the complementation plasmid
pML-B11 are marked by an asterisk (*). Nucleotide (nt) and amino acid (aa) identity between specific sections of the segments is provided.
(b) Sequence alignment of Mk and Mtb B11 loci. The boxed sequences correspond to the annotated Mtb B11 gene. The location of the Tn
(inverted triangle) and putative promoter and terminator sequences are depicted. (c) Predicted secondary structures for the sRNA products
of the B11 genes. The minimum free energy associated with each structure is shown
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0
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C

F I G U R E 4 Northern blot analysis of Mycobacterium kansasii B11 sRNA in M. kansasii strains. (a) Representative northern blot
demonstrating the presence of B11 sRNA in the WT strain (wt-v, lane WT) and complemented strain (13D6-c, lane C) and its absence in
the mutant strain (13D6-v, lane M). Lane MW, molecular weight markers; lane P, B11 probe fragment (100 bp). (b) Northern blot-based
comparison of B11 expression in the WT (WT) and complemented (C) strains. The bands on the blot were quantified by densitometry
analysis using ImageJ software (NIH, available in the public domain). The data represent mean ± SE of quantifications from three northern
blots. *Student's t test p values <.0001
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F I G U R E 5 RT-qPCR expression
analysis of B11 and adjacent genes
in Mycobacterium kansasii strains. (a)
Expression of B11 in macrocolonies. (b)
Expression of B11 in planktonic cells.
(c) Expression of B11 gene neighbors in
macrocolonies. (d) Expression of B11 gene
neighbors in planktonic cells. WT, wt-v; M,
13D6-v; C, 13D6-c. In-bar values reflect
fold reduction in the indicated strain
relative to WT. Data represent mean ± SE
of at least two independent experiments.
Student's t test p values: *<.05; **<.01; ns,
no significant difference (p ≥ .05)
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microcolonies on the pegs of the device (Figure 6a). As noted above,

knowledge, 13D6 is the first Mk biofilm deficient mutant reported,

the strains have comparable planktonic growth (Appendix 2, Figure

and our results provide the first example of a mycobacterial sRNA

A2b) and planktonic growth in MBEC™ plates were indistinguishable

gene involved in biofilm formation.

between both strains, ruling out the possibility that the observed

Overall, our findings indicate that the lack of B11 expression

biofilm formation deficiency of the mutant was due to lack of bacte-

in 13D6 has a pleiotropic effect that impacts (macro)colony mor-

rial growth. The biofilm formation capacity of the B11 locus-com-

phology features and biofilm formation. The molecular mechanism

plemented strain 13D6-c was restored to a level comparable to WT

behind this phenomenon remains to be elucidated. It is tempting to

(Figure 6a). Biofilm quantification using a CV-based colorimetric

speculate, however, that the sRNA regulates Mk genes influencing

method (Figure 6b) recapitulated the results from direct peg ob-

colony morphology features and biofilm formation. Interestingly, re-

servation. Taken together, our results demonstrate that the biofilm

cent studies have shown that expression of Mtb B11 in Msm, which

formation defect of 13D6 is due to a lack of B11 expression. To our

carries its native B11 ortholog (Appendix 2, Figure A4a), leads to
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(a)

(b)
WT

ns

M

*

140 %

*

120 %

C

Biofilm formation

F I G U R E 6 Biofilm formation
by Mycobacterium kansasii strains.
(a) Representative image of crystal
violet-stained MBEC™ device pegs.
(b) Quantification of biofilm formation
on pegs using the crystal violet-based
colorimetric assay. WT, wt-v; M, 13D6-v;
C, 13D6-c; ctrl, sterile medium control.
Data represent mean ± SE of three
independent experiments. *Student's
t test p values <.05; ns, no significant
difference (p ≥ .05)
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F I G U R E 7 Kaplan–Meier survival
curves demonstrating temperaturedependent killing of Galleria mellonella
larvae by Mycobacterium kansasii. WT,
WT strain; M, 13D6 mutant; BC, PBS
buffer control; NIC, noninjected control.
Statistical differences between survival
curves were assessed using the Log-rank
test. p values: ***<.0001; **.0053; *.0362;
ns, no significant difference (p ≥ .05)
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reduced growth and elongated cell shape, and support a model in

Comparison of the survival curves of the infected groups with the

which the Mtb B11 sRNA represses Msm gene expression by a mech-

uninfected controls clearly demonstrated Mk-dependent killing at

anism requiring base-pairing of C-rich loops in the sRNA to G-rich

37°C (Figure 7a). However, we found no difference between the

stretches in mRNA targets (Arnvig & Young, 2009; Mai et al., 2019).

survival curves of the Mk-infected groups. Interestingly, we found

Despite this recent progress, the role of this family of sRNA ortho-

no significant Mk-dependent killing at 25°C (Figure 7b), a tempera-

logs in actinobacterial biology remains poorly understood and fur-

ture much less favorable for Mk replication. Overall, our infection

ther studies to elucidate their regulatory functions are warranted.

experiments revealed that the Tn-dependent disruption of B11
transcription in 13D6 had no substantial impact on virulence in

3.4 | Disruption of B11 transcription does not cause
attenuation in a Galleria mellonella larva killing assay
The GM larva has emerged as a simple and economical invertebrate model host to evaluate virulence of microbial pathogens
and efficacy of antimicrobial compounds (Tsai, Loh, & Proft,
2016). Recent studies have validated the use of this model with

the GM model. To our knowledge, our findings provide the first
demonstration of the susceptibility of GM larva to Mk, thus setting the stage for further exploration of this model for Mk studies.

3.5 | A transposon insertion sequencing approach
identifies 12,071 insertions that do not compromise
Mycobacterium kansasii viability

mycobacteria and shown that larva lethality is species-dependent
(Entwistle & Coote, 2018; Li et al., 2018; Meir, Grosfeld, & Barkan,

TIS approaches are powerful tools for high-throughput gene function

2018; Rwegasila, Mubofu, Nyandoro, Erasto, & Munissi, 2016).

studies and systems-level analysis of microorganisms (van Opijnen &

Given the tractability of this model, we used a GM larva killing

Camilli, 2013). We probed the application of TIS in Mk using a modified

assay to provide a first comparison of the WT and 13D6 strains

TraDIS-type method (Fan et al., 2018; Langridge et al., 2009) custom-

in an in vivo setting. We challenged GM with these strains and

ized for the Tn of ϕMycoMarT7 to identify the insertion sites in a DNA

monitored larval survival during incubation at either 37°C or 25°C.

library pool generated from a nonsaturated Tn mutant library of ≈14,700
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Chromosome

Plasmid

11,696

375

Total TA sites hit relative to total TA sites

12% (of 97,702)

17% (of 2,251)

Intragenic TA sites hit

9,573

312

Intragenic TA sites hit relative to total TA sites hit

82%

83%

Intragenic TA sites hit relative to total intragenic TA sites

12% (of 78,383)

18% (of 1,723)

Intergenic TA sites hit

2,123

63

Intergenic TA sites hit relative to total TA sites hit

18%

17%

Intergenic TA sites hit relative to total intergenic TA sites

11% (of 19,319)

12% (of 528)

Total genes hit

3,474

113

Genes hit relative to total annotated genes

62%

74%

TA B L E 1 Summary of mapped
transposon insertion sites in the
Mycobacterium kansasii chromosome and
plasmid

mutant colonies. The analysis mapped a total of 12,071 different TA in-

preparedness against the development of multidrug resistant Mk CPD,

sertion sites (Table 1, Figure A6 in Appendix 2), indicating that none of

a likely collateral outcome of the pervasive use of anti-TB drugs to curb

these insertions disrupted essential functions required for colony out-

the TB epidemic. In particular, a deeper knowledge of Mk gene function

growth under our experimental conditions. Of the 12,071 insertions,

is needed to help illuminate avenues to new and more effective thera-

9,885 were intragenic, impacting 3,474 (62%) genes of the chromosome

peutics. The establishment of the ϕMycoMarT7 system as an effec-

(Table S1, available at https://doi.org/10.5281/zenodo.3561175) and

tive mutagenesis tool in Mk sets the stage for further use of powerful,

112 (74%) genes of the plasmid pMK12478 (Table S2, available at https

genome-wide scale genetic approaches to accelerate the unraveling of

://doi.org/10.5281/zenodo.3561175). The TA sites hit by the Tn in the

gene function in this pathogen. The use of the ϕMycoMarT7 system

chromosome and in pMK12478 represent 12% and 17% of the total

reported herein led to the discovery of a role of the conserved myco-

TA sites in each amplicon, respectively (Table 1). The chromosome and

bacterial B11 sRNA gene in determination of (macro)colony morphol-

pMK12478 have a comparable percent of coding bp (87% and 84%, re-

ogy features and biofilm formation. It also permitted the identification

spectively), and the same average frequencies of intragenic TA sites (1

of ≈10,000 intragenic Tn insertions that do not impede growth in vitro.

TA/71 bp) and intergenic TA sites (1 TA/43 bp). Notably, however, while

These findings expand our knowledge of Mk gene function. Finally,

the percent of intergenic TA sites hit for the two amplicons relative to the

the demonstration of the susceptibility of GM larvae to Mk opens the

respective total intergenic TA sites is essentially the same (11%–12%),

possibility of using this simple and economical invertebrate infection

the percent of intragenic TA sites hit relative to the amplicon's total intra-

model system for virulence assessment of Mk mutants and in vivo eval-

genic TA sites is considerably depressed in the chromosome (12%) com-

uation of novel antimicrobial lead compounds against Mk.

pared to that of the plasmid (18%). Since insertions disrupting essential
functions required for colony outgrowth are not expected to be repre-
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APPENDIX 1
TA B L E A 1

Bacterial strains

Strain

Characteristics

Mycobacterium kansasii

Source
®

Wild type, subtype 1, type strain (ATCC 12478™)
ΔxylE

integrated at the

American Type Culture Collection
This study

M. kansasii wt-v

M. kansasii carrying empty vector pML1335
phage L5 attB integration site

M. kansasii 13D6

M. kansasii carrying a Tn insertion upstream of B11
(ncMKAN_RS112130c)

This study

M. kansasii 13D6-v

M. kansasii 13D6 carrying empty vector pML1335ΔxylE integrated at
the phage L5 attB integration site

This study

M. kansasii 13D6-c

M. kansasii 13D6 carrying complementation plasmid pML-B11
integrated at the phage L5 attB integration site

This study

Mycobacterium smegmatis mc2155

Wild-type laboratory strain (ATCC® 700084™)

American Type Culture Collection

Escherichia coli DH5α

Strain used for general cloning applications

Thermo Fisher Scientific, Inc.

E. coli DH5α λpir

Strain used for rescue cloning of Tn-containing genomic fragments.
The strain containing the pir gene required for replication of
plasmids with the R6K-derived origin of replication present in the
Tn

Thermo Fisher Scientific, Inc.

E. coli K12 dam−/dcm−

Strain used for propagation of plasmids free of Dam and Dcm
methylation

New England BioLabs, Inc.

TA B L E A 2

Oligonucleotides

Name

Sequence (5′ → 3′)

Comments

GG1

GACTGGCTGCTATTGGGCGAAG

Primers for PCR-based generation of Tn-specific probe

GG2

AGAAGGCGATAGAAGGCGATG

CB2b

CGCTTCCTCGTGCTTTACGGTATCGC

CB2

GAGATAGGGTTGAGTGTTGTTCC

CB3

ATGCGGCCGCTTCGAATACGTATCATCATCGC
CAACACTCCGGGACCAAGGGT

CB7

GATCATGAGGACGGTCACCAATCAAGCATAGGT

CB10

GGCCAGCCCCGTACTCTCGAC

CB11

ATCCAGGTAGTCGCGCAGGACT

CB8c

CATTACTCGGCCTAGAGCCGAGGGTGCATC

CB9c3

AAAAGGGACGACCCCCGCCAGGG

CB49a

CGCCGACCTCGTTGTCCTGGTCT

CB50a

CCAGCCCCAGGTTGGGGTTGA

Primers for sequencing Tn-genome junctions. CB2b and CB2 bind the Km
resistance gene and the oriR6K origin of replication, respectively
Primers for PCR-based generation of the 520-bp chromosomal fragment
carried by pML-B11; genome coordinates 2809862–2810381; NotI and
BspHI sites used in cloning are in bold in CB3 and CB7, respectively
RT-qPCR primers for MKAN_RS24220 (sigA); 135-bp amplicon; genome
coordinates 5589258–5589392
Primers used for PCR-based generation of Mk B11-specific probe for
northern analysis and as RT-qPCR primers for Mk B11; 100-bp amplicon;
genome coordinates 2810109–2810208
RT-qPCR primers for MKAN_RS12130; 104-bp amplicon; genome coordinates
2809046–2809149

CB43a

GCGCGGTTGGCAGGTGTTGTCATT

CB44a

GGCCAGCGCACTGACTCCCA

RT-qPCR primers for MKAN_RS12135; 115-bp amplicon; genome coordinates
2811070–2811184

IS5

AATGATACGGCGACCACCGA

Adapter-specific forward primer used in both PCR reaction rounds (PCR-1
and PCR-2) to generate next-generation Tn-specific deep sequencing
libraries on the Illumina platform.

CB1

CGAGATAGGGTTGAGTGTTGTTC

First Tn-specific reverse primer used in PCR-1 to generate next-generation
Tn-specific deep sequencing libraries on the Illumina platform

CB25.3_R

CAAGCAGAAGACGGCATACGAGATATCAGTATCT
CCGGGGACTTATCAGCCAACC

Second Tn-specific reverse primer used in PCR-2. The primer has the
Illumina flow cell sequence tag (italicized), followed by a sample barcode
(underlined), followed by a random filler sequence (four nucleotides),
followed by a Tn-specific sequence (21 nucleotides; in bold). This will
generate Tn-specific deep sequencing libraries on the Illumina platform
(Continues)
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TA B L E A 2
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(Continued)

Name

Sequence (5′ → 3′)

Comments

CB44.3_R

CAAGCAGAAGACGGCATACGAGATATTATAATCT
CCGGGGACTTATCAGCCAACC

Second Tn-specific reverse primer used in PCR-2. The primer has the Illumina
flow cell sequence tag (italicized), followed by a sample barcode (underlined,
different from that in CB25.3_R), followed by the filler sequence (same as in
CB25.3_R), followed by the Tn-specific sequence (bold). This will generate
Tn-specific deep sequencing libraries on the Illumina platform

Barcodeseq

GGTTGGCTGATAAGTCCCCGGAGAT

Tn-specific index primer used to sequence the sample-specific barcodes
on the Illumina platform. The primer has the Tn-specific sequence (bold)
followed by the filler sequence

SP2

ATCTCCGGGGACTTATCAGCCAACC

Tn-specific read 2 primer used to initiate the paired-end sequencing on the
Illumina platform. The primer has the filler sequence followed by the Tnspecific sequence (bold)

APPENDIX 2

F I G U R E A 1 Section of the original screen plate showing the
abnormal macrocolony morphology phenotype of Mycobacterium
kansasii 13D6. Scale bar = 2 mm
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F I G U R E A 2 The transposon insertion
in Mycobacterium kansasii 13D6 does
not compromise planktonic growth,
nor does it affect cell morphology. (a)
Representative phase contrast (PC) and
differential interference contrast (DIC)
microscopy images showing cells from
exponentially growing cultures of the
WT (left) and mutant (right) strains. Scale
bars = 5 µm. Images were acquired using
a Nikon Eclipse Ti inverted microscope
(Nikon Instruments Inc.) (b) Growth curves
of Mk strains. WT, wt-v; M, 13D6-v; and
C, 13D6-c. The growth curve data were
generated in a multiwell plate-based
growth assay as described in Section
2. Values of each time point represent
mean ± SE of three independent growth
curves

(a)

PC

PC

DIC

DIC

Growth (A 595)

(b) 1.0

WT
M
C

0.8
0.6
0.4
0.2
0.0
0

2

4

6

8

10

12

14

16

18

20

Incubation time (days)

L

WT

M

L

WT

M

Kb
8.6
7.4
6.1
4.9
3.6
2.8
2.0
1.9

3.5 kb

F I G U R E A 3 Southern blot hybridization analysis of Mycobacterium kansasii 13D6. Agarose gel electrophoresis of SacII-digested genomic
DNA (left panel) and southern blot membrane after hybridization with a Tn-specific probe (right panel). Lanes: L, DNA molecular weight
ladder; WT, WT strain; M, 13D6 mutant
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(a)
Mtb
Mk
Mb
BCG
Mm
Mu
Mp
Ma
Mc
Mi
Ms
Mab
Mt
JLS
Mn
Msm
Mph
Mr
Mg
Mv

TACTCGGCCAT-AGCCGAGGGTGTATCAGTCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTGGCAGCC
TACTCGGCCTAGAGCCGAGGGTGCATCAGCCCGACCCCCCGGGGCTGAAGCACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTGGGGA
TACTCGGCCAT-AGCCGAGGGTGTATCAGTCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCCC-CTGGCGGGGGTCGTCC-CTTTTGGCAGCC
TACTCGGCCAT-AGCCGAGGGTGTATCAGTCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCCC-CTGGCGGGGGTCGTCC-CTTTTGGCAGCC
TACTCGGCCACGAGCCGAGGGTGCATCAGTCCGACCCCCCGGGGCTGAAGCACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTGTGGGGT
TACTCGGCCATGAGCCGAGGGTGCATCAGTCCGACCCGCCGGGGCTGAAGCACGACGACCTCCGCCTCCTCCCCCCCCCTGGCGGGGGTCGTCC-CTTTTGTGGGGT
TACTCGGCCTG-AGCCGAGGGTGTATCAGCCCGACCCCCCGGGGCTGATACACGACGACCCTCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTCCGGT
TACTCGGCCTG-AGCCGAGGGTGTATCAGCCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTCGGGT
TACTCGGCCTG-AGCCGAGGGTGTATCAGCCCGACCCCCCGGGGCTGATACACGACGACCCTCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTAGGGT
TACTCGGCCTG-AGCCGAGGGTGTATCAGCCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTCGGGT
CACTCGGCTTA-TGCTGAGGGTGTATCGGCCCGACCCCCCGGGGTTGATACACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCT-TTTTTAACCGGT
TACTCGGCT-A-TGCCGAGTGTGTCTCAGCCCGACCCCCCGGGGCTGATGCACGACGACCCTCGCCTCCTCCCCCC--CTGGCGAGGGTCGTCCTCTTTTCTGGGGA
TACCCGGGTTA-TGCCGGGTGTGCATCAGTCCGACCCCCCGGGACTGATACACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCT-CTTTTTCCGCAC
TACCCGGGTTA-TGCCGGGTGTGCATCAGCCCGACCCCCCGGGGCTGATACACGACGACCTCCGCCTCCTCCCCCCC-CTGGCGGGGGTCGTCC-CTTTTTCGGGGT
CACTCGGCCTT-AGCCGAGTGTGGATCAGCCCGACCCCCCGGGGCTGATACACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTTCCGGAC
TACTCGGCTTA-TGCCGAG-GTGTATCAGCCCGACCCCCCGGGGCTGATACGCGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCTTCTTTTCCAGGGA
TACTCGGCT-A-TGCCGAGTGTGTCTCAGCCCGACCCCCCGGGGCTGAAGCACGACGACCCTCGCCTCCTCCCCCC--CTGGCGAGGGTCGTCCTCTTTTCTGGGGA
CACTCGGCTTA-TGCTGAGTGTGCATCAGCCCGACCCCCCGGGGCTGATACACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTGTGGGGG
TACTCGGCTTA-TGCCGAGTGTGCATCAGCCCGACCCCCCGGGGCTGATACACGACGACCTCCGCCTCCTCCCCCCC-CTGGCGGGGGTCGTCC-CTTTTGTGGGGT
TACTCGGCTTA-TGCCGGGTGTGCATCAGCCCGACCCCCCGGGGCTGATACACGACGACCTCCGCCTCCTCCCCCC--CTGGCGGGGGTCGTCC-CTTTTCTGGGGT
** ***
** * * *** ** * ******* ***** *** * ******** ************** ****** ******** *****

4099478 - 4099376
2810205 - 2810102
4041237 - 4041134
4072591 - 4072488
6232277 - 6232174
4706834 - 4706729
298523 - 298421
459934 - 460036
3634216 - 3634114
422436 - 422538
4191134 - 4191032
433363 - 433465
4464192 - 4464090
5443228 - 5443125
5321769 - 5321667
6242833 - 6242731
417657 - 417759
2177225 - 2177327
1438719 - 1438822
5803054 - 5802952

(b)
Mtb
Mk
Mb
BCG
Mm
Mu
Mp
Ma
Mc
Mi
Ms
Mab
Mt
JLS
Mn
Msm
Mph
Mr
Mg
Mv

CGT-CCGG-TACTTGCGTGACTGCGCACTGTCATGTGTATAGTAAGCAT
GTG-CAAT-TACTTGCGTGAATGCCATCTGGCATGTGTATAGTAAGCAT
CGT-CCGG-TACTTGCGTGACTGCGCACTGTCATGTGTATAGTAAGCAT
CGT-CCGG-TACTTGCGTGACTGCGCACTGTCATGTGTATAGTAAGCAT
GCA-CCGA-TACTTGCGTTAATCCAGTCTGGCATGTGTATAGTAAGCAT
GCA-CCGA-TACTTGCGTTAATCCAGTCTGGCATGTGTATAGTAAGCAT
GAA-AGAG-CTATTGCGTTACCGCGGCTTGTCATGTGTATAGTAAGCAT
AAA-TGAT-CTATTGCGTTACTGCCGACTGTCATGTGTATAGTAAGCAT
AAA-TGAT-GTCTTGCGTTACTCCGGCTTGTCATGTGTATAGTAAGCAT
AAA-TGAT-CTATTGCGTTATTGCGGACTGTCATGTGTATAGTAAGCAT
GGTGACAA-CACTTGCGCCGGACCGGCATGTCGTGTGTATAGTG-TCAT
GCC-GATTGGTCTTGCCACCCTCACCCGGTTCGTGTGTATAGTGGG-GT
GAT-TCGG-GGCTTGCGCCGCGGGCCAGGGTCGTGTGTATAGTGAGCAT
CAT-GCGG-GACTTGCATTCCGTGGCCGTACCGTGTGTATAGTGGGCGT
CGT-CCGC-TACTTGCACTGCACGGCGAATCCGTGTGTATAGTGGCAAT
GTC-AGAT-CTCTTGCGACTTTCGGCAGTTACATGTGTATAGTGAGCAT
GCC-GATTGGTCTTGCCACCCTCACCTGGTTCGTGTGTATAGTGGG-GT
ACAATCAA-GTCTTGCGCCGACCCGTGCAGCCGTGTGTATAGTGAGTAT
AAT-TCGA-TACTTGCGCTGGGCCAGACTGGCGTGTGTATAGTGGGCAT
ATT-TCGA-TACTTGCGGTGGCCCTGTCTGGCGTGTGTATAGTGGGCAT
****
* **********
*
–35

19 bp
SigA-dependent promoter

4099525
2810252
4041284
4072638
6232324
4706881
298570
459887
3634263
422389
4191181
433316
4464239
5443275
5321816
6242880
417610
2177177
1438672
5803101

-

4099479
2810206
4041238
4072592
6232278
4706835
298524
459933
3634217
422435
4191135
433362
4464193
5443229
5321770
6242834
417656
2177224
1438718
5803055

–10

F I G U R E A 4 Conservation of the B11 gene locus in mycobacteria. (a) Sequence alignment of Mycobacterium tuberculosis B11,
Mycobacterium kansasii B11, and predicted orthologs in other mycobacteria. (b) Sequence alignment of B11 promoter regions. Gray shading
highlights identity with the Mtb sequence. Asterisks below the alignment indicate 100% conservation. The bar under the alignment of B11
orthologs marks the sequence annotated for Mtb B11. Abbreviations to the left and chromosomal coordinates to the right of the sequences
correspond to the following bacteria and NCBI reference sequences, respectively. Mtb: M. tuberculosis strain H37Rv, NC_000962.3;
Mk: M. kansasii strain ATCC 12478, NC_022663.1; Mb: Mycobacterium bovis strain AF2122/97, NC_002945; BCG: M. bovis BCG Pasteur
1173P2, NC_008769.1; Mm: Mycobacterium marinum strain M, NC_010612.1; Mu: Mycobacterium ulcerans strain Agy99, NC_008611.1; Mp:
Mycobacterium parascrofulaceum strain ATCC BAA-614 SCAFFOLD1, NZ_GG770553.1; Ma: Mycobacterium avium strain 104, NC_008595.1;
Mc: Mycobacterium columbiense strain CECT 3035, NZ_CP020821.1; Mi: Mycobacterium intracellulare strain ATCC 13950, NC_016946.1; Ms:
Mycobacterium sinense strain JDM601, NC_015576.1; Mab: Mycobacterium abscessus strain ATCC 19977, NC_010397.1; Mt: Mycobacterium
thermoresistible strain NCTC10409, NZ_LT906483.1; JLS: M. sp. JLS, NC_009077.1; Mn: Mycobacterium neoaurum strain VKM Ac-1815D,
NC_023036.2; Msm: Mycobacterium smegmatis strain mc2155, NC_018289.1; Mph: Mycobacterium phlei strain NCTC8151, NZ_LR134347.1;
Mr: Mycobacterium rhodesiae strain NBB3, NC_016604.1; Mg: Mycobacterium gilvium strain PYR-GCK, NC_009338.1; and Mv: Mycobacterium
vanbaalenii strain PYR-1, NC_008726.1

Msm
Mk

4764505 CAATGGTAGAGCCCTAGTCTTCCAAACTAGCTACGCGGGTTCGATTCCCGTCGCCCGCTCGG
||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| |
1225397 CAATGGTAGAGCCCTAGTCTTCCAAACTAGCGACGCGGGTTCGATTCCCGTCGCCCGCTCAG

4764566
1225458

F I G U R E A 5 Mycobacteriophage L5 integration attB site in Mycobacterium kansasii. Alignment of the 62-bp attB site in Mycobacterium
smegmatis strain mc2155 (Msm, NCBI reference sequence: NC_008596.1) and the predicted attB site in M. kansasii (Mk, NCBI reference
sequence: NC_022663.1). Longer bar, 43-bp attB common core. Shorter bar, 29-bp necessary and sufficient for attB function. Chromosomal
coordinates are indicated
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F I G U R E A 6 Histograms showing
overviews of frequency distributions
of Tn insertions and TA dinucleotide
sites along the chromosome (a) and the
plasmid pMK12478 (b) of Mycobacterium
kansasii. The data of the Tn insertions for
the chromosome and plasmid are derived
from Tables S1 and S2, respectively.
The data of TA dinucleotide sites for the
chromosome and plasmid are derived
from NCBI Reference Sequences
NC_022663.1 and NC_022654.1,
respectively. The data presented for the
chromosome and plasmid are organized in
bins of 50,000 and 2,500 bp, respectively.
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APPENDIX 3
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Component

Volume (µl)

End repair and A-tailing reaction product

20

Adapter stock

5

PCR-grade water

1.7

A. Critical materials and reagents required

Ligation buffer

10

• KAPA HyperPlus Kit (Cat. no.: KR1145, Kapa Biosystems)

DNA ligase

3.3

• Kapa Beads/SPRI (Cat. no.: KK8000, Kapa Biosystems)

Total volume

40

GENERATION OF FRAGMENT LIBRARIES FOR ϕMYCOMART7
TRANSPOSON

INSERTION

SEQUENCING

USING

ILLUMINA

NEXT-GENERATION SEQUENCING TECHNOLOGY

• Magnetic separation rack
• OneTaq Hot Start DNA Polymerase (Cat. no.: M0481S, NEB)
• Qubit dsDNA HS Assay Kit (Cat. no.: Q32851, Thermo Fisher

10. Mix thoroughly and centrifuge briefly.
11. Incubate at 20°C for 15 min. Proceed immediately to next step.

Scientific)
• Transposon specific primers: IS5; CB1; CB25.3_R; CCB44.3_R;

E. Post-ligation cleanup

barcodeseq; and SP2 (see Table A2 in Appendix 1)

12. To the same tube, add the following.

• Input DNA, 100–500 ng
B. Enzymatic fragmentation
1. Add the following components in the order noted. Keep tubes
on ice.
Component

Volume (µl)

Input DNA in water (if required to make the volume
higher)

11.7

KAPA fragmentation buffer (10×)

1.7

KAPA fragmentation enzyme

3.3

Total volume

16.7

Component

Volume (µl)

Adapter ligated reaction product

40

KAPA beads

32

13.	Mix thoroughly by vortexing and pipetting up and down multiple
times. Incubate for 5 min at room temperature.
14. Place the tube on a magnet rack and wait until the supernatant
is clear. Carefully remove and discard the supernatant.
15. Keep the tube on the magnet rack and add 200 µl of 80%
ethanol.
16. Carefully remove and discard the ethanol.

2. Vortex gently and spin down briefly. Return the tubes to ice.

17. Repeat steps 15–16 for a total of 2 washes.
18. Dry the beads for 2 min to evaporate any residual ethanol.

Proceed immediately to the next step.
3. Incubate the tubes in a thermocycler for 4 min at 37°C for a DNA
input of 10 ng or for 15 min at 37°C for a DNA input of 500 ng.

19. Remove the tubes from the magnet rack and resuspend beads in
12 µl of nuclease-free water.
20. Incubate the tube at room temperature for 2 min to elute DNA

The fragmentation target size is 350 bp.

off the beads.
C. End repair and A-tailing

21. Place the tube on a magnet rack and wait for the supernatant to

4. In the same tube in which enzymatic fragmentation was performed, assemble each end repair and A-tailing reactions. Keep

be clear.
22. Transfer the clear supernatant to a fresh tube.

tubes on ice. (Same composition for 10 and 500 ng of DNA input.)
Component

Volume (µl)

Fragmented DNA

16.7

End repair & A-tailing buffer

2.3

End repair & A-tailing enzyme mix
Total volume

23. Set up and run PCR-1 as follows.
Reagent

Volume (µl)

1

OneTaq polymerase

10

20

PCR-grade water

3

Primer mix: IS5 + CB1; 10 µM each

2

Library from step 22

5

5. Vortex gently and spin down briefly. Return the reaction tubes to
ice.
6. Incubate in a thermocycler at 65°C for 30 min. Hold at 4°C.
7. Proceed immediately to the next step.
D. Adapter ligation
8. Take 1.8 µl of a 25-µM adapter stock tube and make the volume
up with water such that the final volume is 5 µl.
9. In the same tube in which the end repair and A-tailing were performed, add the following.

F. First transposon-specific PCR—PCR-1

Temperature

Time

Cycles

94˚C

30 s

1

94˚C

15 s

10

60˚C

30 s

10

68˚C

45 s

10

68˚C

5 min

1
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Temperature

Time

Cycles

4˚C

Hold

—

H. Final library QC
26. Analyze 3 µl of PCR-2 reaction
by agarose gel electrophoresis.
When DNA of transposon mutant

24. Perform a post-PCR cleanup. To the 20 µl PCR 1 reaction, add

pools is used, a library-like smear

14 µl of KAPA beads and mix well. Repeat steps 13–22, but elute

in the transposon enriched library

in 15 µl of nuclease-free water.

should be seen. The smear should
not be present for controls done

G. Second transposon-specific PCR—hemi-nested PCR-2

with wild-type DNA as input.

25. Set up and run PCR-2 as follows.

See example image; lanes: M,

Reagent

Volume (µl)

OneTaq polymerase

10

PCR-grade water

3

Primer mix: IS5 + CB25.3_R or CB44.3_R; 10 µM
each

2

Cleaned PCR-1 product from step 24

5

GeneRuler 1 kb Plus DNA Ladder
(Thermo Fisher Scientific); 1, sample with DNA of M. kansasii transposon mutant pool as input DNA;
2, sample with DNA of M. kansasii
wild type as input DNA; 3, No DNA template PCR control.
27. Clean the final PCR-2 reaction. Repeat step 24.

Temperature

Time

Cycles

94˚C

30 s

1

94˚C

15 s

15

60˚C

30 s

15

68˚C

45 s

15

68˚C

5 min

1

4˚C

Hold

—

28. Using 1 µl from cleaned PCR-2 and Qubit dsDNA HS Assay Kit,
check the concentration of the library.
29. Use another 1 µl from cleaned PCR-2 to verify for the library size
on the Agilent Bioanalyzer.
30. The final library is then sequenced as described in the Materials
and Methods section of the manuscript proper.

